Margaret E. Schot
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 3
- Drug Transport and Resistance Mechanisms 2
-
- Breast Cancer Treatment Studies 3
- Cancer Genomics and Diagnostics 2
- Co-authors
- Jos Beijnen (14 shared papers)Jan H.M. Schellens (13 shared papers)Wim W. ten Bokkel Huinink (9 shared papers)Hilde Rosing (8 shared papers)C.M.F. Kruijtzer (4 shared papers)Elaine Marie Paul (1 shared paper)Roxanne C. Jewell (1 shared paper)Franciska J. Koopman (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Anti-Cancer Drugs (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Investigational New Drugs (2 papers)British Journal of Cancer (2 papers)
- Partner nations
- NetherlandsUnited KingdomGermany
In The Last Decade
Margaret E. Schot
23 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 98
- Oncology 727
- Cancer Research 391
- Biomaterials 310
- Pharmaceutical Science 111
- Pharmacology 132
Countries citing papers authored by Margaret E. Schot
This map shows the geographic impact of Margaret E. Schot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret E. Schot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret E. Schot more than expected).
Fields of papers citing papers by Margaret E. Schot
This network shows the impact of papers produced by Margaret E. Schot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret E. Schot. The network helps show where Margaret E. Schot may publish in the future.
Co-authors
The 25 scholars most cited alongside Margaret E. Schot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 390 | |
| 2 | 2014 | 345 | |
| 3 | 2001 | 235 | |
| 4 | 2001 | 171 | |
| 5 | 2002 | 105 | |
| 6 | 2002 | 98 | |
| 7 | 2010 | 63 | |
| 8 | 2001 | 60 | |
| 9 | 2003 | 40 | |
| 10 | 2006 | 32 | |
| 11 | 2006 | 26 | |
| 12 | 2009 | 23 | |
| 13 | 1998 | 22 | |
| 14 | 2019 | 20 | |
| 15 | 2017 | 18 | |
| 16 | 2002 | 13 | |
| 17 | 1999 | 12 | |
| 18 | 2013 | 11 | |
| 19 | 1999 | 9 | |
| 20 | 2013 | 9 |
About Margaret E. Schot
Margaret E. Schot is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Behavioral Neuroscience and Molecular Biology, having authored 25 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Cancer therapeutics and mechanisms (4 papers), Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Treatments and Mutations (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Chemotherapy-related skin toxicity (1 paper). The work is most often cited by research in Oncology (727 citations), Cancer Research (391 citations), Biomaterials (310 citations), Pharmaceutical Science (111 citations) and Pharmacology (132 citations). Margaret E. Schot has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include Jos Beijnen, Jan H.M. Schellens, Wim W. ten Bokkel Huinink, Hilde Rosing, C.M.F. Kruijtzer, Elaine Marie Paul, Roxanne C. Jewell, Franciska J. Koopman, Emiel J. Th. Rutgers and Marieke Evelien Straver. Their work appears in journals such as Journal of Clinical Oncology, Anti-Cancer Drugs, Cancer Chemotherapy and Pharmacology, Investigational New Drugs and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.